Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 29.41B | 29.65B | 29.80B | 29.74B | 27.96B | 25.44B |
Gross Profit | 7.52B | 7.61B | 7.46B | 7.34B | 7.53B | 8.01B |
EBITDA | 3.45B | 4.11B | 3.54B | 3.27B | 3.24B | 3.90B |
Net Income | 2.22B | 2.11B | 1.98B | 1.77B | 1.69B | 2.20B |
Balance Sheet | ||||||
Total Assets | 35.04B | 36.28B | 34.46B | 36.16B | 32.33B | 30.48B |
Cash, Cash Equivalents and Short-Term Investments | 4.28B | 5.46B | 2.76B | 5.66B | 6.10B | 6.70B |
Total Debt | 0.00 | 70.52M | 122.88M | 341.18M | 77.22M | 47.19M |
Total Liabilities | 7.19B | 7.95B | 7.45B | 11.49B | 9.05B | 8.52B |
Stockholders Equity | 27.84B | 28.33B | 27.01B | 24.67B | 23.27B | 21.97B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.80B | -2.73B | 461.84M | 401.45M | 2.26B |
Operating Cash Flow | 0.00 | 3.57B | 615.51M | 2.31B | 1.23B | 2.82B |
Investing Cash Flow | 0.00 | -242.67M | -3.16B | -2.32B | -1.16B | -424.84M |
Financing Cash Flow | 0.00 | -606.63M | -434.81M | -425.76M | -736.11M | -443.25M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥15.47B | 8.53 | 2.69% | 9.10% | 18.98% | ||
76 Outperform | ¥160.29B | 14.78 | 2.32% | 3.68% | 18.67% | ||
74 Outperform | ¥4.86B | 9.69 | 1.84% | 5.48% | 72.64% | ||
70 Outperform | ¥15.63B | 7.34 | 4.13% | -0.51% | 6.16% | ||
69 Neutral | ¥61.41B | 20.60 | 2.27% | 2.47% | -4.91% | -21.12% | |
67 Neutral | ¥250.86B | 13.17 | 6.48% | 2.78% | 5.05% | -11.96% | |
58 Neutral | ¥11.41B | 9.83 | 3.12% | -5.57% | -1.82% |